HUTCHMED (China) (HCM) Total Debt (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Total Debt of $77.8 million for Q2 2026, down 16.75% year-over-year from $93.4 million in Q2 2025, and up 549.42% quarter-over-quarter from $12.0 million in Q4 2025.
HUTCHMED (China) (HCM) Total Debt (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Total Debt for 12 consecutive years, with $77.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Debt fell 16.75% year-over-year to $77.8 million; the TTM figure through Jun 2026 stood at $77.8 million (down 16.75% YoY), while the FY2025 annual figure was $12.0 million, up 81.02% from the prior year.
- Total Debt grew to $77.8 million in Q2 2026 per HCM's latest filing, from $12.0 million in the prior quarter.
- Across five years, Total Debt topped out at $10.2 billion in Q4 2023 and bottomed at $836000.0 in Q2 2022.
- Historically, Total Debt has averaged $1.2 billion across 5 years, with a median of $42.1 million in 2023.
- Annual changes were most pronounced in 2023 — Total Debt surged 438655.81% — and 2024, when it plunged 99.9%.
- HUTCHMED (China)'s Total Debt stood at $2.3 million in 2022, then soared by 438655.81% to $10.2 billion in 2023, then slumped by 99.9% to $10.7 million in 2024, then gained by 12.46% to $12.0 million in 2025, then surged by 549.42% to $77.8 million in 2026.
- Business Quant data shows HCM's Total Debt at $77.8 million in Q2 2026, $12.0 million in Q4 2025, and $93.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | 94.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.79 Mn |
| Dec 31, 2025 | 11.98 Mn |
| Jun 30, 2025 | 93.44 Mn |
| Dec 31, 2024 | 10.65 Mn |
| Jun 30, 2024 | 82.10 Mn |
| Dec 31, 2023 | 10.15 Bn |
| Jun 30, 2023 | 42.10 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Jun 30, 2022 | 836,000.00 |
| Dec 31, 2021 | 3.45 Mn |
| Jun 30, 2021 | 26.88 Mn |
| Mar 31, 2021 | 26.87 Mn |
| Dec 31, 2020 | 401,000.00 |
| Jun 30, 2020 | 26.84 Mn |
| Dec 31, 2019 | 366,000.00 |
| Mar 31, 2019 | 26.76 Mn |
| Dec 31, 2018 | 27.17 Mn |
| Jun 30, 2018 | 37.38 Mn |
| Dec 31, 2017 | 7.02 Mn |
| Jun 30, 2017 | 28.14 Mn |